Found: 10
Select item for more details and to access through your institution.
Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Serum anti-TSTD2 antibody as a biomarker for atherosclerosis-induced ischemic stroke and chronic kidney disease.
- Published in:
- Medicine International (2754-3242), 2023, v. 3, n. 1, p. 1, doi. 10.3892/mi.2022.64
- By:
- Publication type:
- Article
Risk Factors in Chronic Subdural Hematoma: Comparison of Irrigation with Artificial Cerebrospinal Fluid and Normal Saline in a Cohort Analysis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0103703
- By:
- Publication type:
- Article
Association between serum anti-ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.
- Published in:
- International Journal of Molecular Medicine, 2020, v. 46, n. 4, p. 1274
- By:
- Publication type:
- Article
Pseudoleukocoria.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 133, doi. 10.1186/1471-2407-14-452
- By:
- Publication type:
- Article
Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-452
- By:
- Publication type:
- Article
Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Complementation of Escherichia coli ubiF mutation by Caenorhabditis elegans CLK-1, a product of the longevity gene of the nematode worm
- Published in:
- FEBS Letters, 2003, v. 543, n. 1-3, p. 174, doi. 10.1016/S0014-5793(03)00419-8
- By:
- Publication type:
- Article
Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.
- Published in:
- Cancer Science, 2020, v. 111, n. 12, p. 4453, doi. 10.1111/cas.14652
- By:
- Publication type:
- Article